New England Journal of Medicine· 2013Q1

Complement-Binding Anti-HLA Antibodies and Kidney-Allograft Survival

Alexandre Loupy, Carmen Lefaucheur, Déwi Vernerey, Christof Prugger et al.

837citations
Q1SCImago
2013year

Short summary

Kidney transplant recipients with complement-binding donor-specific anti-HLA antibodies after surgery had a significantly lower 5-year graft survival rate (54%) compared to those without such antibodies (94%).

AI-generated from the title and abstract; the full text is not read.

TakeawaysIn the app

Key pointsIn the app

Ask the paperIn the app

The rest is in the Pofolia app

Takeaways, key points and questions to the paper; new summaries every day for your field. Free.

Get it on Google Play Download on the App Store

Field: Transplantation

TransplantationMedicine